Monthly
US$200
Billed every month
Sign in to subscribeMinoxidil Liniment
As of 13 November 2026, for Minoxidil Liniment, 52 applications are listed as under review at China's CDE; 8 companies have filed new generic applications in 2026; the chemical-drug catalogue lists 0 holders.
Companies, stages and changes, with each record available on this page.
Last 90 days: Marketing application approved: 1 applicationAccepted: 12 applicationsNo longer listed under review: 5 applicationsSupplement delivery: 1 applicationNotification delivery: 4 applications
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.
Catalogue holders0View records ↓
Under-review filings52View records ↓
This year’s generic filers8View records ↓
NHSA approval numbers90View records ↓
API companies with A status16View records ↓
Chemical-drug catalogue
Loaded records: 0 holders; 0 in the quality-and-efficacy consistency-evaluation category, and 0 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | ||||||
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 90 distinct approval numbers and 56 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| Le Fu Si Health Industry Shareholding Company romanized | 国药准字H20254833 | See source | Not stated by source | XD11AXM104T001010100318 | NHSA |
| Hangzhou Min Sheng Health Pharma Co., Ltd. romanized | 国药准字H20253660 | See source | Not stated by source | XD11AXM104T001010100500 | NHSA |
| Shenyang San Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20265680 | See source | Not stated by source | XD11AXM104T001010101313 | NHSA |
| Changzhou Si Yao Pharmaceutical Co., Ltd. romanized | 国药准字H20253969 | See source | Not stated by source | XD11AXM104T001010101389 | NHSA |
| Jiangsu Kang Yuan Pharma Co., Ltd. romanized | 国药准字H20233226 | See source | Not stated by source | XD11AXM104T001010101463 | NHSA |
| Jiangsu Run Bang Pharma Co., Ltd. romanized | 国药准字H20253787 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001010101475 | NHSA |
| Jiangsu Shen Hua Pharma Co., Ltd. romanized | 国药准字H20264966 | 2%(60ml:1.2g) | Not stated by source | XD11AXM104T001010101477 | NHSA |
| Jiangsu Tian Shi Li Di Yi Pharma Co., Ltd. romanized | 国药准字H20263690 | See source | Not stated by source | XD11AXM104T001010101500 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20243294 | 5%(60ml:3g) | Not stated by source | XD11AXM104T001010101503 | NHSA |
| Yao Da Pharmaceutical Co., Ltd. romanized | 国药准字H20263276 | See source | Not stated by source | XD11AXM104T001010101770 | NHSA |
| Yuan Da Pharmaceuticals (Xian Tao) Pharmaceutical Co., Ltd. romanized | 国药准字H20253551 | See source | Not stated by source | XD11AXM104T001010101862 | NHSA |
| Sichuan Mei Da Kang Hua Kang Pharma Co., Ltd. romanized | 国药准字H20052642 | 100ml:2.0g | Not stated by source | XD11AXM104T001010102087 | NHSA |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20253209 | See source | Not stated by source | XD11AXM104T001010102180 | NHSA |
| Shanxi Zhen Dong An Xin Biopharmaceutical Co., Ltd. romanized | 国药准字H20020190 | 60ml:1.2g | Not stated by source | XD11AXM104T001010102868 | NHSA |
| Tai Kang Hai En Pharma Co., Ltd. romanized | 国药准字H20263019 | See source | Not stated by source | XD11AXM104T001010103172 | NHSA |
| Le Tai Pharma (Lan Xi) Co., Ltd. romanized | 国药准字H20256124 | See source | Not stated by source | XD11AXM104T001010103643 | NHSA |
| Lu Nan Bei Te Pharmaceutical Co., Ltd. romanized | 国药准字H20243099 | See source | Not stated by source | XD11AXM104T001010104010 | NHSA |
| Shandong Lu Kang Pharmaceuticals Group Sai Te Co., Ltd. romanized | 国药准字H20263407 | See source | Not stated by source | XD11AXM104T001010104131 | NHSA |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H20255139 | See source | Not stated by source | XD11AXM104T001010104187 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20249389 | See source | Not stated by source | XD11AXM104T001010104339 | NHSA |
| Hefei Hua Wei Pharma Co., Ltd. romanized | 国药准字H20255037 | See source | Not stated by source | XD11AXM104T001010104388 | NHSA |
| Hangzhou Kang En Bei Pharmaceutical Co., Ltd. romanized | 国药准字H20249417 | See source | Not stated by source | XD11AXM104T001010104489 | NHSA |
| Zhejiang Zhe Bei Pharma Co., Ltd. romanized | 国药准字H20263305 | See source | Not stated by source | XD11AXM104T001010104755 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20254011 | See source | Not stated by source | XD11AXM104T001010104918 | NHSA |
| Hunan Qian Jin Xiang Jiang Pharma Co., Ltd. romanized | 国药准字H20265489 | See source | Not stated by source | XD11AXM104T001010104960 | NHSA |
| Jiang You Pharmaceutical (Chang De) Co., Ltd. romanized | 国药准字H20254406 | See source | Not stated by source | XD11AXM104T001010105031 | NHSA |
| Jiangxi Hai Er Si Pharma Co., Ltd. romanized | 国药准字H20264878 | See source | Not stated by source | XD11AXM104T001010105291 | NHSA |
| Zhejiang Yuan Li Jian Pharma Co., Ltd. romanized | 国药准字H20244586 | See source | Not stated by source | XD11AXM104T001010109207 | NHSA |
| Li Cai Gansu Xi Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20244435 | See source | Not stated by source | XD11AXM104T001010109579 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20243297 | See source | Not stated by source | XD11AXM104T001010109920 | NHSA |
| Jiangsu Chen Pai Bang De Pharma Co., Ltd. romanized | 国药准字H20249808 | See source | Not stated by source | XD11AXM104T001010110112 | NHSA |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20253430 | 2%(60ml:1.2g) | Not stated by source | XD11AXM104T001010180651 | NHSA |
| Liaoning Xin Gao Pharmaceutical Co., Ltd. romanized | 国药准字H20255338 | See source | Not stated by source | XD11AXM104T001010181199 | NHSA |
| Jiangsu Ziyond Pharmaceutical Co., Ltd. | 国药准字H20254032 | See source | Not stated by source | XD11AXM104T001010181475 | NHSA |
| Yi Nan Li Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20253678 | See source | Not stated by source | XD11AXM104T001010183011 | NHSA |
| Shandong Hua Bo Kai Sheng Bio Technology Co., Ltd. romanized | 国药准字H20263325 | See source | Not stated by source | XD11AXM104T001010183034 | NHSA |
| Jia Shi (Hunan) Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20256384 | See source | Not stated by source | XD11AXM104T001010183048 | NHSA |
| Guangzhou Hu Rui Pharmaceuticals Technology Development Co., Ltd. romanized | 国药准字H20263521 | See source | Not stated by source | XD11AXM104T001010183642 | NHSA |
| Hainan Zhen Dong Bio Technology Co., Ltd. romanized | 国药准字H20244275 | See source | Not stated by source | XD11AXM104T001010183703 | NHSA |
| Jiangsu Rui Shi Bio Technology Co., Ltd. romanized | 国药准字H20253979 | 2%(60ml∶1.2g) | Not stated by source | XD11AXM104T001010183832 | NHSA |
| Ren Xi Pharmaceuticals Technology Hebei Co., Ltd. romanized | 国药准字H20256089 | See source | Not stated by source | XD11AXM104T001010183846 | NHSA |
| Shandong Tai He Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254396 | See source | Not stated by source | XD11AXM104T001010184043 | NHSA |
| Hangzhou Mu Yuan Biopharmaceuticals Technology Co., Ltd. romanized | 国药准字H20243067 | See source | Not stated by source | XD11AXM104T001010184135 | NHSA |
| Shandong Fu Rui Da Pharmaceuticals Group Co., Ltd. romanized | 国药准字H20244724 | See source | Not stated by source | XD11AXM104T001010184211 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254134 | See source | Not stated by source | XD11AXM104T001010184221 | NHSA |
| Ningbo Mei Shu Pharma Co., Ltd. romanized | 国药准字H20244727 | See source | Not stated by source | XD11AXM104T001010184223 | NHSA |
| Sheng Jia (Bin Hai) Biopharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255533 | See source | Not stated by source | XD11AXM104T001010184450 | NHSA |
| Name not romanized | 国药准字H20253675 | See source | Not stated by source | XD11AXM104T001010184612 | NHSA |
| Beijing Nuo Bo Te Bio Technology Co., Ltd. romanized | 国药准字H20255541 | See source | Not stated by source | XD11AXM104T001010184613 | NHSA |
| Jinan Zhong Hai Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20249312 | See source | Not stated by source | XD11AXM104T001010184624 | NHSA |
| Shenzhen Shi Lang Bo Biopharmaceuticals Co., Ltd. romanized | 国药准字H20253978 | See source | Not stated by source | XD11AXM104T001010184694 | NHSA |
| Guangdong Quan Xin Quan Yi Pharma Co., Ltd. romanized | 国药准字H20253973 | 2%(60ml:1.2g) | Not stated by source | XD11AXM104T001010184701 | NHSA |
| Hebei Yi Hai Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20264374 | See source | Not stated by source | XD11AXM104T001010185039 | NHSA |
| Hefei Yuan Zhi Pharmaceuticals Technology Kai Fa Co., Ltd. romanized | 国药准字H20265912 | See source | Not stated by source | XD11AXM104T001010185197 | NHSA |
| Wuhan Hua Er Bio Technology Co., Ltd. romanized | 国药准字H20264582 | See source | Not stated by source | XD11AXM104T001010185564 | NHSA |
| Shenyang San Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20265680 | See source | Not stated by source | XD11AXM104T001010201313 | NHSA |
| Changzhou Si Yao Pharmaceutical Co., Ltd. romanized | 国药准字H20253969 | See source | Not stated by source | XD11AXM104T001010201389 | NHSA |
| Jiangsu Run Bang Pharma Co., Ltd. romanized | 国药准字H20253787 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001010201475 | NHSA |
| Yuan Da Pharmaceuticals (Xian Tao) Pharmaceutical Co., Ltd. romanized | 国药准字H20253551 | See source | Not stated by source | XD11AXM104T001010201862 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20249389 | See source | Not stated by source | XD11AXM104T001010204339 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20254011 | See source | Not stated by source | XD11AXM104T001010204918 | NHSA |
| Li Cai Gansu Xi Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20244435 | See source | Not stated by source | XD11AXM104T001010209579 | NHSA |
| Hainan Zhen Dong Bio Technology Co., Ltd. romanized | 国药准字H20244275 | See source | Not stated by source | XD11AXM104T001010283703 | NHSA |
| Jiangsu Rui Shi Bio Technology Co., Ltd. romanized | 国药准字H20253979 | 2%(60ml∶1.2g) | Not stated by source | XD11AXM104T001010283832 | NHSA |
| Ren Xi Pharmaceuticals Technology Hebei Co., Ltd. romanized | 国药准字H20256089 | See source | Not stated by source | XD11AXM104T001010283846 | NHSA |
| Shandong Tai He Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254396 | See source | Not stated by source | XD11AXM104T001010284043 | NHSA |
| Shandong Fu Rui Da Pharmaceuticals Group Co., Ltd. romanized | 国药准字H20244724 | See source | Not stated by source | XD11AXM104T001010284211 | NHSA |
| Hefei Yuan Zhi Pharmaceuticals Technology Kai Fa Co., Ltd. romanized | 国药准字H20265912 | See source | Not stated by source | XD11AXM104T001010285197 | NHSA |
| Shenyang San Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20265680 | See source | Not stated by source | XD11AXM104T001010301313 | NHSA |
| Jiangsu Run Bang Pharma Co., Ltd. romanized | 国药准字H20253787 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001010301475 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20249389 | See source | Not stated by source | XD11AXM104T001010304339 | NHSA |
| Li Cai Gansu Xi Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20244435 | See source | Not stated by source | XD11AXM104T001010309579 | NHSA |
| Jiangsu Rui Shi Bio Technology Co., Ltd. romanized | 国药准字H20253979 | 2%(60ml∶1.2g) | Not stated by source | XD11AXM104T001010383832 | NHSA |
| Shandong Tai He Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254396 | See source | Not stated by source | XD11AXM104T001010384043 | NHSA |
| Shandong Fu Rui Da Pharmaceuticals Group Co., Ltd. romanized | 国药准字H20244724 | See source | Not stated by source | XD11AXM104T001010384211 | NHSA |
| Hefei Yuan Zhi Pharmaceuticals Technology Kai Fa Co., Ltd. romanized | 国药准字H20265912 | See source | Not stated by source | XD11AXM104T001010385197 | NHSA |
| Jiangsu Run Bang Pharma Co., Ltd. romanized | 国药准字H20253787 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001010401475 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20249389 | See source | Not stated by source | XD11AXM104T001010404339 | NHSA |
| Jiangsu Run Bang Pharma Co., Ltd. romanized | 国药准字H20253787 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001010501475 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20249389 | See source | Not stated by source | XD11AXM104T001010504339 | NHSA |
| Jiangsu Run Bang Pharma Co., Ltd. romanized | 国药准字H20253787 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001010601475 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20249389 | See source | Not stated by source | XD11AXM104T001010604339 | NHSA |
| Hangzhou Min Sheng Health Pharma Co., Ltd. romanized | 国药准字H20253661 | See source | Not stated by source | XD11AXM104T001020100500 | NHSA |
| Shenyang San Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20265681 | See source | Not stated by source | XD11AXM104T001020101313 | NHSA |
| Jiangsu Shen Hua Pharma Co., Ltd. romanized | 国药准字H20264967 | 5%(60ml︰3.0g) | Not stated by source | XD11AXM104T001020101477 | NHSA |
| Jiangsu Tian Shi Li Di Yi Pharma Co., Ltd. romanized | 国药准字H20263691 | See source | Not stated by source | XD11AXM104T001020101500 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20243293 | 2%(60ml:1.2g) | Not stated by source | XD11AXM104T001020101503 | NHSA |
| Yuan Da Pharmaceuticals (Xian Tao) Pharmaceutical Co., Ltd. romanized | 国药准字H20253552 | See source | Not stated by source | XD11AXM104T001020101862 | NHSA |
| Sichuan Mei Da Kang Hua Kang Pharma Co., Ltd. romanized | 国药准字H20052642 | 100ml:2.0g | Not stated by source | XD11AXM104T001020102087 | NHSA |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20253210 | See source | Not stated by source | XD11AXM104T001020102180 | NHSA |
| Shanxi Zhen Dong An Xin Biopharmaceutical Co., Ltd. romanized | 国药准字H20020190 | 60ml:1.2g | Not stated by source | XD11AXM104T001020102868 | NHSA |
| Le Tai Pharma (Lan Xi) Co., Ltd. romanized | 国药准字H20256125 | See source | Not stated by source | XD11AXM104T001020103643 | NHSA |
| Lu Nan Bei Te Pharmaceutical Co., Ltd. romanized | 国药准字H20244460 | See source | Not stated by source | XD11AXM104T001020104010 | NHSA |
| Shandong Lu Kang Pharmaceuticals Group Sai Te Co., Ltd. romanized | 国药准字H20263408 | See source | Not stated by source | XD11AXM104T001020104131 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20249390 | See source | Not stated by source | XD11AXM104T001020104339 | NHSA |
| Hefei Hua Wei Pharma Co., Ltd. romanized | 国药准字H20255038 | See source | Not stated by source | XD11AXM104T001020104388 | NHSA |
| Hangzhou Kang En Bei Pharmaceutical Co., Ltd. romanized | 国药准字H20249454 | See source | Not stated by source | XD11AXM104T001020104489 | NHSA |
| Zhejiang Zhe Bei Pharma Co., Ltd. romanized | 国药准字H20263306 | See source | Not stated by source | XD11AXM104T001020104755 | NHSA |
| Jiang You Pharmaceutical (Chang De) Co., Ltd. romanized | 国药准字H20254407 | See source | Not stated by source | XD11AXM104T001020105031 | NHSA |
| Jiangxi Hai Er Si Pharma Co., Ltd. romanized | 国药准字H20264878 | See source | Not stated by source | XD11AXM104T001020105291 | NHSA |
| Zhejiang Yuan Li Jian Pharma Co., Ltd. romanized | 国药准字H20249221 | See source | Not stated by source | XD11AXM104T001020109207 | NHSA |
| Li Cai Gansu Xi Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20244436 | See source | Not stated by source | XD11AXM104T001020109579 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20243296 | See source | Not stated by source | XD11AXM104T001020109920 | NHSA |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20253431 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001020180651 | NHSA |
| Liaoning Xin Gao Pharmaceutical Co., Ltd. romanized | 国药准字H20255338 | See source | Not stated by source | XD11AXM104T001020181199 | NHSA |
| Jiangsu Ziyond Pharmaceutical Co., Ltd. | 国药准字H20254033 | See source | Not stated by source | XD11AXM104T001020181475 | NHSA |
| Shandong Hua Bo Kai Sheng Bio Technology Co., Ltd. romanized | 国药准字H20263326 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001020183034 | NHSA |
| Guangzhou Hu Rui Pharmaceuticals Technology Development Co., Ltd. romanized | 国药准字H20263522 | See source | Not stated by source | XD11AXM104T001020183642 | NHSA |
| Hainan Zhen Dong Bio Technology Co., Ltd. romanized | 国药准字H20244276 | See source | Not stated by source | XD11AXM104T001020183703 | NHSA |
| Jiangsu Rui Shi Bio Technology Co., Ltd. romanized | 国药准字H20253980 | 5%(60ml∶3.0g) | Not stated by source | XD11AXM104T001020183832 | NHSA |
| Shandong Tai He Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254397 | See source | Not stated by source | XD11AXM104T001020184043 | NHSA |
| Shandong Fu Rui Da Pharmaceuticals Group Co., Ltd. romanized | 国药准字H20244749 | See source | Not stated by source | XD11AXM104T001020184211 | NHSA |
| Ningbo Mei Shu Pharma Co., Ltd. romanized | 国药准字H20244728 | See source | Not stated by source | XD11AXM104T001020184223 | NHSA |
| Name not romanized | 国药准字H20253675 | See source | Not stated by source | XD11AXM104T001020184612 | NHSA |
| Beijing Nuo Bo Te Bio Technology Co., Ltd. romanized | 国药准字H20255542 | See source | Not stated by source | XD11AXM104T001020184613 | NHSA |
| Jinan Zhong Hai Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20249313 | See source | Not stated by source | XD11AXM104T001020184624 | NHSA |
| Guangdong Quan Xin Quan Yi Pharma Co., Ltd. romanized | 国药准字H20253974 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001020184701 | NHSA |
| Hebei Yi Hai Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20264375 | See source | Not stated by source | XD11AXM104T001020185039 | NHSA |
| Shenyang San Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20265681 | See source | Not stated by source | XD11AXM104T001020201313 | NHSA |
| Yuan Da Pharmaceuticals (Xian Tao) Pharmaceutical Co., Ltd. romanized | 国药准字H20253552 | See source | Not stated by source | XD11AXM104T001020201862 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20249390 | See source | Not stated by source | XD11AXM104T001020204339 | NHSA |
| Zhejiang Yuan Li Jian Pharma Co., Ltd. romanized | 国药准字H20249221 | See source | Not stated by source | XD11AXM104T001020209207 | NHSA |
| Li Cai Gansu Xi Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20244436 | See source | Not stated by source | XD11AXM104T001020209579 | NHSA |
| Hainan Zhen Dong Bio Technology Co., Ltd. romanized | 国药准字H20244276 | See source | Not stated by source | XD11AXM104T001020283703 | NHSA |
| Jiangsu Rui Shi Bio Technology Co., Ltd. romanized | 国药准字H20253980 | 5%(60ml∶3.0g) | Not stated by source | XD11AXM104T001020283832 | NHSA |
| Shandong Tai He Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254397 | See source | Not stated by source | XD11AXM104T001020284043 | NHSA |
| Shandong Fu Rui Da Pharmaceuticals Group Co., Ltd. romanized | 国药准字H20244749 | See source | Not stated by source | XD11AXM104T001020284211 | NHSA |
| Name not romanized | 国药准字H20253675 | See source | Not stated by source | XD11AXM104T001020284612 | NHSA |
| Shenyang San Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20265681 | See source | Not stated by source | XD11AXM104T001020301313 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20249390 | See source | Not stated by source | XD11AXM104T001020304339 | NHSA |
| Li Cai Gansu Xi Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20244436 | See source | Not stated by source | XD11AXM104T001020309579 | NHSA |
| Jiangsu Rui Shi Bio Technology Co., Ltd. romanized | 国药准字H20253980 | 5%(60ml∶3.0g) | Not stated by source | XD11AXM104T001020383832 | NHSA |
| Shandong Tai He Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254397 | See source | Not stated by source | XD11AXM104T001020384043 | NHSA |
| Shandong Fu Rui Da Pharmaceuticals Group Co., Ltd. romanized | 国药准字H20244749 | See source | Not stated by source | XD11AXM104T001020384211 | NHSA |
| Name not romanized | 国药准字H20253675 | See source | Not stated by source | XD11AXM104T001020384612 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20249390 | See source | Not stated by source | XD11AXM104T001020404339 | NHSA |
| Name not romanized | 国药准字H20253675 | See source | Not stated by source | XD11AXM104T001020484612 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20249390 | See source | Not stated by source | XD11AXM104T001020504339 | NHSA |
| Name not romanized | 国药准字H20253675 | See source | Not stated by source | XD11AXM104T001020584612 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20249390 | See source | Not stated by source | XD11AXM104T001020604339 | NHSA |
| Name not romanized | 国药准字H20253675 | See source | Not stated by source | XD11AXM104T001020684612 | NHSA |
| Name not romanized | 国药准字H20253675 | See source | Not stated by source | XD11AXM104T001020784612 | NHSA |
| Jiangsu Ji Ming Pharmaceuticals Co., Ltd. romanized | 国药准字H20263842 | See source | Not stated by source | XD11AXM104T001030101503 | NHSA |
| Sichuan Mei Da Kang Hua Kang Pharma Co., Ltd. romanized | 国药准字H20052642 | 100ml:2.0g | Not stated by source | XD11AXM104T001030102087 | NHSA |
| Shanxi Zhen Dong An Xin Biopharmaceutical Co., Ltd. romanized | 国药准字H20060626 | 60ml:3g | Not stated by source | XD11AXM104T001030102868 | NHSA |
| Hangzhou Kang En Bei Pharmaceutical Co., Ltd. romanized | 国药准字H20249417 | See source | Not stated by source | XD11AXM104T001030104489 | NHSA |
| Guangdong Quan Xin Quan Yi Pharma Co., Ltd. romanized | 国药准字H20253974 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001030184701 | NHSA |
| Guangdong Quan Xin Quan Yi Pharma Co., Ltd. romanized | 国药准字H20253974 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001030284701 | NHSA |
| Guangdong Quan Xin Quan Yi Pharma Co., Ltd. romanized | 国药准字H20253974 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001030384701 | NHSA |
| Guangdong Quan Xin Quan Yi Pharma Co., Ltd. romanized | 国药准字H20253974 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001030484701 | NHSA |
| Jiangsu Ji Ming Pharmaceuticals Co., Ltd. romanized | 国药准字H20263841 | See source | Not stated by source | XD11AXM104T001040101503 | NHSA |
| Sichuan Mei Da Kang Hua Kang Pharma Co., Ltd. romanized | 国药准字H20052642 | 100ml:2.0g | Not stated by source | XD11AXM104T001040102087 | NHSA |
| Shanxi Zhen Dong An Xin Biopharmaceutical Co., Ltd. romanized | 国药准字H20060626 | 60ml:3g | Not stated by source | XD11AXM104T001040102868 | NHSA |
| Guangdong Quan Xin Quan Yi Pharma Co., Ltd. romanized | 国药准字H20253974 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001040184701 | NHSA |
| Sichuan Mei Da Kang Hua Kang Pharma Co., Ltd. romanized | 国药准字H20052642 | 100ml:2.0g | Not stated by source | XD11AXM104T001050102087 | NHSA |
| Shanxi Zhen Dong An Xin Biopharmaceutical Co., Ltd. romanized | 国药准字H20060626 | 60ml:3g | Not stated by source | XD11AXM104T001050102868 | NHSA |
| Guangdong Quan Xin Quan Yi Pharma Co., Ltd. romanized | 国药准字H20253974 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001050184701 | NHSA |
| Sichuan Mei Da Kang Hua Kang Pharma Co., Ltd. romanized | 国药准字H20269019 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001060102087 | NHSA |
| Shanxi Zhen Dong An Xin Biopharmaceutical Co., Ltd. romanized | 国药准字H20060626 | 60ml:3g | Not stated by source | XD11AXM104T001060102868 | NHSA |
| Guangdong Quan Xin Quan Yi Pharma Co., Ltd. romanized | 国药准字H20253974 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001060184701 | NHSA |
| Sichuan Mei Da Kang Hua Kang Pharma Co., Ltd. romanized | 国药准字H20269019 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001060202087 | NHSA |
| Shanxi Zhen Dong An Xin Biopharmaceutical Co., Ltd. romanized | 国药准字H20020190 | 60ml:1.2g | Not stated by source | XD11AXM104T001060202868 | NHSA |
| Shanxi Zhen Dong An Xin Biopharmaceutical Co., Ltd. romanized | 国药准字H20020190 | 60ml:1.2g | Not stated by source | XD11AXM104T001070102868 | NHSA |
| Guangdong Quan Xin Quan Yi Pharma Co., Ltd. romanized | 国药准字H20253974 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001070184701 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 52 filings and 29 distinct first applicants.
Generic 42 · Supplement 10
New generic filings in 2026
Loaded records: 13 filings and 8 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Jiangsu Peng Yao Pharma Co., Ltd. romanized | CYHS2602200 | Generic | 2026/09/03 | Not stated by source | CDE |
| Jiangsu Peng Yao Pharma Co., Ltd. romanized | CYHS2602199 | Generic | 2026/09/03 | Not stated by source | CDE |
| Zhong Shan Bai Ling Bio Technology Co., Ltd. romanized; Zhongshan Wanhan Pharmaceuticals Co., Ltd. | CYHS2601811 | Generic | 2026/07/28 | Not stated by source | CDE |
| CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Guangdong Ke Hong Pharma Co., Ltd. romanized | CYHS2601676 | Generic | 2026/07/14 | Not stated by source | CDE |
| CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD; Guangdong Ke Hong Pharma Co., Ltd. romanized | CYHS2601675 | Generic | 2026/07/14 | Not stated by source | CDE |
| Anhui De Hong Sheng Pharmaceutical Co., Ltd. romanized; Zhejiang Ding Tai Pharma Co., Ltd. romanized | CYHS2601529 | Generic | 2026/06/29 | Not stated by source | CDE |
| Hubei Chang Jiang Rui Yi Pharmaceuticals Technology Co., Ltd. romanized; Yuan Da Pharmaceuticals (Xian Tao) Pharmaceutical Co., Ltd. romanized | CYHS2601475 | Generic | 2026/06/23 | Not stated by source | CDE |
| Hubei Chang Jiang Rui Yi Pharmaceuticals Technology Co., Ltd. romanized; Yuan Da Pharmaceuticals (Xian Tao) Pharmaceutical Co., Ltd. romanized | CYHS2601474 | Generic | 2026/06/23 | Not stated by source | CDE |
| Hubei Kang Zheng Pharma Co., Ltd. romanized | CYHS2601401 | Generic | 2026/06/12 | Not stated by source | CDE |
| Hubei Kang Zheng Pharma Co., Ltd. romanized | CYHS2601400 | Generic | 2026/06/12 | Not stated by source | CDE |
| Hangzhou Wan Bang Tian Cheng Pharma Co., Ltd. romanized | CYHS2600537 | Generic | 2026/02/26 | Not stated by source | CDE |
| Shandong Jian Bin Pharmaceuticals Technology Co., Ltd. romanized; Shanghai Li Xiang Pharmaceutical Co., Ltd. romanized | CYHS2600286 | Generic | 2026/01/27 | Not stated by source | CDE |
| Shandong Jian Bin Pharmaceuticals Technology Co., Ltd. romanized; Shanghai Li Xiang Pharmaceutical Co., Ltd. romanized | CYHS2600285 | Generic | 2026/01/27 | Not stated by source | CDE |
API registrations
Non-component matches: 16 companies with A status and 4 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 米诺地尔 · No verified English name | Zhejiang Xian Feng Technology Group Co., Ltd. romanized | Y20260000654 | I | Exact ingredient | 2026/08/31 | CDE |
| 米诺地尔 · No verified English name | Zhong Shan Bai Sheng Bio Technology Co., Ltd. romanized | Y20260000153 | I | Exact ingredient | 2026/03/09 | CDE |
| 米诺地尔 · No verified English name | Shandong Ji Kun Biopharmaceutical Co., Ltd. romanized | Y20250001475 | I | Exact ingredient | 2026/01/07 | CDE |
| 米诺地尔 · No verified English name | He Bi Shi Xin He Pharma Co., Ltd. romanized | Y20250000583 | I | Exact ingredient | 2025/07/01 | CDE |
| 米诺地尔 · No verified English name | Liaoning Hong Shan Hu Pharma Co., Ltd. romanized | Y20250000348 | A | Exact ingredient | 2026/08/28 | CDE |
| 米诺地尔 · No verified English name | Shandong Rui Shun Pharma Co., Ltd. romanized | Y20240001177 | A | Exact ingredient | 2026/06/18 | CDE |
| 米诺地尔 · No verified English name | Fujian Nan Fang Pharmaceutical Co., Ltd. romanized | Y20240000460 | A | Exact ingredient | 2025/11/28 | CDE |
| 米诺地尔 · No verified English name | Sichuan Mei Da Kang Hua Kang Pharma Co., Ltd. romanized | Y20240000123 | A | Exact ingredient | 2025/12/31 | CDE |
| 米诺地尔 · No verified English name | VPL CHEMICALS PRIVATE LIMITED | Y20230000589 | A | Exact ingredient | 2025/12/29 | CDE |
| 米诺地尔 · No verified English name | Shanxi Zhen Dong Tai Sheng Pharmaceutical Co., Ltd. romanized | Y20230000847 | A | Exact ingredient | 2025/02/22 | CDE |
| 米诺地尔 · No verified English name | Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | Y20230000415 | A | Exact ingredient | 2026/03/27 | CDE |
| 米诺地尔 · No verified English name | Tian Ke (Jing Zhou) Pharmaceutical Co., Ltd. romanized | Y20220001342 | A | Exact ingredient | 2026/03/13 | CDE |
| 米诺地尔 · No verified English name | Qi Dong Dong Yue Pharma Co., Ltd. romanized | Y20220000673 | A | Exact ingredient | 2024/04/16 | CDE |
| 米诺地尔 · No verified English name | Zhongshan Wanhan Pharmaceuticals Co., Ltd. | Y20220000201 | A | Exact ingredient | 2025/11/21 | CDE |
| 米诺地尔 · No verified English name | Kumar Organic Products Ltd. | Y20200001457 | A | Exact ingredient | 2024/02/08 | CDE |
| 米诺地尔 · No verified English name | Changzhou Jin Cheng Pharmaceutical Factory romanized | Y20200000808 | A | Exact ingredient | 2024/11/07 | CDE |
| 米诺地尔 · No verified English name | Changzhou Si Yao Pharmaceutical Co., Ltd. romanized | Y20190004912 | A | Exact ingredient | 2025/11/22 | CDE |
| 米诺地尔 · No verified English name | Tianjin Drug Research Institute Pharma Co., Ltd. romanized | Y20190002654 | A | Exact ingredient | 2024/12/19 | CDE |
| 米诺地尔 · No verified English name | Fu Le Ma Hong Kai (Da Lian) Pharmaceuticals Co., Ltd. romanized | Y20190000309 | A | Exact ingredient | 2025/10/29 | CDE |
| 米诺地尔 · No verified English name | Flamma S.p.A | Y20180001649 | A | Exact ingredient | 2024/10/30 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/13 06:39. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
This source was last successfully updated at 2026/11/12 18:32; current coverage may be incomplete.
-
2026/11/11No longer listed under review
Shenzhen Shi Lang Bo Biopharmaceuticals Co., Ltd. romanized; Jiangsu Ziyond Pharmaceutical Co., Ltd.
CYHB2601512
Fact date: 2026/11/11 · Site observation date: 2026/11/11
Accepted: 2026/08/07
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/10 (approval no.: —; approval date: 2026/11/09); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 18
NMPA · Table row 18 ↗ View source ↗ -
2026/11/11Accepted
Fu Yuan Pharma Co., Ltd. romanized
CYHB2602050
Fact date: 2026/11/11 · Site observation date: 2026/11/12
View source ↗ -
2026/11/11Accepted
Fu Yuan Pharma Co., Ltd. romanized
CYHB2602049
Fact date: 2026/11/11 · Site observation date: 2026/11/12
View source ↗ -
2026/11/09Supplement delivery
Shenzhen Shi Lang Bo Biopharmaceuticals Co., Ltd. romanized
CYHB2601512
Fact date: 2026/11/09 · Publication date: 2026/11/10 · Site observation date: 2026/11/10
Supplemental application; excluded from new marketing approvals.
View source · Table row 18 ↗ -
2026/11/09Accepted
Hainan Hai Shen Tong Zhou Pharmaceutical Co., Ltd. romanized; Hefei Hua Wei Pharma Co., Ltd. romanized
CYHB2602031
Fact date: 2026/11/09 · Site observation date: 2026/11/10
View source ↗ -
2026/11/09Accepted
Hainan Hai Shen Tong Zhou Pharmaceutical Co., Ltd. romanized; Hefei Hua Wei Pharma Co., Ltd. romanized
CYHB2602030
Fact date: 2026/11/09 · Site observation date: 2026/11/10
View source ↗ -
2026/11/03Marketing application approved
Guangdong Heng Jian Pharmaceutical Co., Ltd. romanized
CYHS2404576 · 国药准字H20266485
Fact date: 2026/11/03 · Publication date: 2026/11/05 · Site observation date: 2026/11/06
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 16 ↗ -
2026/10/27Accepted
Jiangsu Run Bang Pharma Co., Ltd. romanized; Zhongshan Wanhan Pharmaceuticals Co., Ltd.
CYHB2601964
Fact date: 2026/10/27 · Site observation date: 2026/10/28
View source ↗ -
2026/10/27Accepted
Jiangsu Run Bang Pharma Co., Ltd. romanized; Zhongshan Wanhan Pharmaceuticals Co., Ltd.
CYHB2601963
Fact date: 2026/10/27 · Site observation date: 2026/10/28
View source ↗ -
2026/10/23No longer listed under review
Shandong Hua Bo Kai Sheng Bio Technology Co., Ltd. romanized; Yan Tai Lu Yin Pharma Co., Ltd. romanized
CYHB2600880
Fact date: 2026/10/23 · Site observation date: 2026/10/23
Accepted: 2026/05/08
not on the CDE under-review list in this snapshot; NMPA published notification delivery for this acceptance number on 2026/10/22; the notification contents are not public and the outcome remains unverified; this is a supplemental application, not counted as a new marketing approval · NMPA source · row 5
NMPA · Table row 5 ↗ View source ↗ -
2026/10/23No longer listed under review
Shandong Hua Bo Kai Sheng Bio Technology Co., Ltd. romanized; Yan Tai Lu Yin Pharma Co., Ltd. romanized
CYHB2600879
Fact date: 2026/10/23 · Site observation date: 2026/10/23
Accepted: 2026/05/08
not on the CDE under-review list in this snapshot; NMPA published notification delivery for this acceptance number on 2026/10/22; the notification contents are not public and the outcome remains unverified; this is a supplemental application, not counted as a new marketing approval · NMPA source · row 4
NMPA · Table row 4 ↗ View source ↗ -
2026/10/23No longer listed under review
Shandong Hua Bo Kai Sheng Bio Technology Co., Ltd. romanized; Yan Tai Lu Yin Pharma Co., Ltd. romanized
CYHB2600878
Fact date: 2026/10/23 · Site observation date: 2026/10/23
Accepted: 2026/05/08
not on the CDE under-review list in this snapshot; NMPA published notification delivery for this acceptance number on 2026/10/22; the notification contents are not public and the outcome remains unverified; this is a supplemental application, not counted as a new marketing approval · NMPA source · row 3
NMPA · Table row 3 ↗ View source ↗ -
2026/10/23No longer listed under review
Shandong Hua Bo Kai Sheng Bio Technology Co., Ltd. romanized; Yan Tai Lu Yin Pharma Co., Ltd. romanized
CYHB2600877
Fact date: 2026/10/23 · Site observation date: 2026/10/23
Accepted: 2026/05/08
not on the CDE under-review list in this snapshot; NMPA published notification delivery for this acceptance number on 2026/10/22; the notification contents are not public and the outcome remains unverified; this is a supplemental application, not counted as a new marketing approval · NMPA source · row 2
NMPA · Table row 2 ↗ View source ↗ -
2026/10/22Notification delivery
Shandong Hua Bo Kai Sheng Bio Technology Co., Ltd. romanized
CYHB2600880
Fact date: 2026/10/22 (Publication date) · Publication date: 2026/10/22 · Site observation date: 2026/11/03
Notification delivered; the specific outcome remains to be checked.
View source · Table row 5 ↗ -
2026/10/22Notification delivery
Shandong Hua Bo Kai Sheng Bio Technology Co., Ltd. romanized
CYHB2600879
Fact date: 2026/10/22 (Publication date) · Publication date: 2026/10/22 · Site observation date: 2026/11/03
Notification delivered; the specific outcome remains to be checked.
View source · Table row 4 ↗ -
2026/10/22Notification delivery
Shandong Hua Bo Kai Sheng Bio Technology Co., Ltd. romanized
CYHB2600878
Fact date: 2026/10/22 (Publication date) · Publication date: 2026/10/22 · Site observation date: 2026/11/03
Notification delivered; the specific outcome remains to be checked.
View source · Table row 3 ↗ -
2026/10/22Notification delivery
Shandong Hua Bo Kai Sheng Bio Technology Co., Ltd. romanized
CYHB2600877
Fact date: 2026/10/22 (Publication date) · Publication date: 2026/10/22 · Site observation date: 2026/11/03
Notification delivered; the specific outcome remains to be checked.
View source · Table row 2 ↗ -
2026/09/24Accepted
Hangzhou Min Sheng Health Pharma Co., Ltd. romanized; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized
CYHB2601814
Fact date: 2026/09/24 · Site observation date: 2026/10/22
View source ↗ -
2026/09/24Accepted
Hangzhou Min Sheng Health Pharma Co., Ltd. romanized; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized
CYHB2601813
Fact date: 2026/09/24 · Site observation date: 2026/10/22
View source ↗ -
2026/09/11Accepted
Hunan Ke Rui Biopharmaceutical Co., Ltd. romanized; Zhejiang Zhe Bei Pharma Co., Ltd. romanized
CYHB2601726
Fact date: 2026/09/11 · Site observation date: 2026/10/22
View source ↗ -
2026/09/11Accepted
Hunan Ke Rui Biopharmaceutical Co., Ltd. romanized; Zhejiang Zhe Bei Pharma Co., Ltd. romanized
CYHB2601725
Fact date: 2026/09/11 · Site observation date: 2026/10/22
View source ↗ -
2026/09/03Accepted
Jiangsu Peng Yao Pharma Co., Ltd. romanized
CYHS2602200
Fact date: 2026/09/03 · Site observation date: 2026/10/21
View source ↗ -
2026/09/03Accepted
Jiangsu Peng Yao Pharma Co., Ltd. romanized
CYHS2602199
Fact date: 2026/09/03 · Site observation date: 2026/10/21
View source ↗
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/13 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/13 06:39
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/13 06:41
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/12 18:32 · Current coverage may be incomplete
First index-page publication dates: 2026-10-29 to 2026-11-13; 2 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/13 08:09 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 7/30; discovered pending details: 13. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Minoxidil Liniment
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Sign in to subscribeYearly
US$1,920
Billed every year
US$160 per month
Sign in to subscribeNeed more than 10 followed products or more than 5 recipients? Contact us.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy